Abdel-Rahmène Azzouzi

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

Promoter Hypermethylation Is Associated With Tumor Location, Stage, and Subsequent Progression in Transitional Cell Carcinoma

James W.F. Catto, Abdel-Rahmène Azzouzi, Ishtiaq Rehman et al. · Journal of Clinical Oncology · 2005 · 311 citations

Medicine, Molecular Biology, Urology +15

Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States

Samir S. Taneja, James Bennett, Jonathan Coleman et al. · The Journal of Urology · 2016 · 68 citations · Full text

Medicine, Oncology, Urology +15

Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

Henk G. van der Poel, Laurence Klotz, Gerald L. Andriole et al. · World Journal of Urology · 2015 · 25 citations

Medicine, Oncology, Urology +16

Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway

Jean-Nicolas Cornu, Étienne Audet‐Walsh, Sarah Drouin et al. · World Journal of Urology · 2016 · 15 citations

Medicine, Genetics, Urology +16